Sponsor

Changping Laboratory

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Changping Laboratory appears in 15 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials15
Recruiting shown2
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

15 shown
SCAN Targeted Epidural Modulation for Parkinson's DiseaseNCT06919822 · lead sponsor · 2025-12-08
RECRUITING
pBFS-guided rTMS Over DMPFC for Treatment-Resistant DepressionNCT06350396 · lead sponsor · 2024-04-17
UNKNOWN
pBFS Guided rTMS Over Different Targets for Treatment-Resistant DepressionNCT06255561 · lead sponsor · 2024-02-20
UNKNOWN
Neuromodulation of Different Doses to Treat TRD Guided by pBFS TechniqueNCT06112652 · lead sponsor · 2023-12-04
SUSPENDED
rTMS Therapy for Treatment-Resistant Depression With Different Targets Guided by pBFSNCT06095778 · lead sponsor · 2023-11-06
UNKNOWN
pBFS Guided rTMS Treating Mild Alzheimer's Disease(AD)NCT05872243 · lead sponsor · 2023-09-05
COMPLETED
pBFS-Guided rTMS Therapy Over Different Targets for Treatment-Resistant DepressionNCT05976009 · lead sponsor · 2023-08-29
UNKNOWN
pBFS Guided VS "5-cm Rule" rTMS Over DLPFC for MDDNCT05964023 · lead sponsor · 2023-08-20
UNKNOWN
pBFS Guided rTMS Therapy Over Different Targets for Treatment-Resistant DepressionNCT05976022 · lead sponsor · 2023-08-04
UNKNOWN
pBFS Guided 20min Inter-session Interval rTMS Treatment for MDDNCT05957341 · lead sponsor · 2023-07-30
UNKNOWN
pBFS-guided High-dose TMS Over DMPFC for Treatment-resistant Major Depressive DisorderNCT05964036 · lead sponsor · 2023-07-21
UNKNOWN
pBFS Guided rTMS Over DMPFC for Treatment-Resistant DepressionNCT05948839 · lead sponsor · 2023-07-11
UNKNOWN
The Dosage Effect of pBFS Guided rTMS Treatment for MDDNCT05842278 · lead sponsor · 2023-07-07
UNKNOWN
fMRI-guided Transcranial Magnetic Stimulation Treatment for Parkinson's DiseaseNCT06734676 · lead sponsor · 2023-05-29
COMPLETED
Individualized Transcranial Magnetic Stimulation in Parkinsonian DisordersNCT07570212 · collaborator · 2025-12-22
RECRUITING

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Changping Laboratory as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

lead sponsor14
collaborator1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.